ArticleMolecular therapy. Methods & clinical development2018

Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major.

Nikoletta Psatha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.